Lymphoma Clinical Trials
Lymphoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for lymphoma. Corterve aggregates actively recruiting Lymphoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Lymphoma studies
- A Study of LY4584180 in Adult Participants With Previously Treated Blood CancersNCT07226843PHASE1Eli Lilly and CompanyLymphoma, Non-Hodgkin'sScottsdale, Arizona
- Tissue Collection for Studies of Lymph CancerNCT01676805National Cancer Institute (NCI)Hodgkin DiseaseBethesda, Maryland
- A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic LeukemiaNCT05091424PHASE1Hoffmann-La RocheChronic Lymphocytic Leukemia or Small Lymphocytic LymphomaRochester, Minnesota
- Emapalumab Prevention of CAR-T Cell Associated ToxicitiesNCT06550141PHASE2Marcela V. Maus, M.D.,Ph.D.Large B-cell LymphomaBoston, Massachusetts
- Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line TherapyNCT07479797PHASE3Kite, A Gilead CompanyRelapsed or Refractory Large B-cell LymphomaGoodyear, Arizona
- A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)NCT07519772PHASE1, PHASE2Merck Sharp & Dohme LLCLymphoma, Non-HodgkinDenver, Colorado
- A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaNCT05533775PHASE1, PHASE2Hoffmann-La RocheMature B-Cell Non-Hodgkin LymphomaBirmingham, Alabama
- Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)NCT07509151PHASE3AstraZenecaChronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHVLa Jolla, California
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerNCT00006518National Cancer Institute (NCI)HIVBethesda, Maryland
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsNCT06418204Wake Forest University Health SciencesBreast CarcinomaFairbanks, Alaska
- A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )NCT07101328PHASE1Eli Lilly and CompanyLymphoma, Non-HodgkinDuarte, California
- Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC GeneNCT07069699PHASE1, PHASE2National Cancer Institute (NCI)Burkitt LymphomaIrvine, California
Lymphoma trials by state
Lymphoma trials by metro
Frequently asked questions
- How do I find recruiting Lymphoma clinical trials?
- Browse the actively recruiting Lymphoma studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Lymphoma clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Lymphoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.